Lithium titration starts with a low dose, typically 300 mg three times daily (900 mg total), and increases in small increments every 5 to 7 days based on blood level results. The goal is to reach a target serum concentration of 0.8 to 1.2 mEq/L for acute treatment or 0.8 to 1.0 mEq/L for long-term maintenance. Because lithium has a narrow gap between a therapeutic dose and a toxic one, the process relies heavily on regular blood draws and careful timing.
Before Starting: Baseline Tests
Lithium is cleared almost entirely by the kidneys and can affect thyroid function over time, so a set of baseline labs is standard before the first dose. These typically include kidney function markers (urea, creatinine, and estimated GFR), thyroid function, calcium, electrolytes, a full blood count, and weight or BMI. An ECG may also be ordered, particularly for older adults or anyone with a history of heart problems. These baseline values become the reference point for tracking changes over months and years of treatment.
Starting Dose
The FDA-approved starting dose for adults is 300 mg of lithium carbonate taken three times daily, for a total of 900 mg per day. This applies to both standard capsules/tablets and oral solution formulations. Some clinicians start lower, particularly in older adults or people with reduced kidney function, where a starting dose of 150 to 300 mg once or twice daily is common. The kidneys clear lithium more slowly as they age, so the same dose can produce significantly higher blood levels in someone over 65 compared to a younger adult.
Extended-release tablets are also available. They release lithium more gradually, with peak blood concentrations arriving 2 to 6 hours after a dose rather than the 15 minutes to 3 hours seen with immediate-release forms. Extended-release versions can reduce some of the peak-related side effects like nausea and tremor, though the total daily dose and titration approach remain similar.
How the Dose Goes Up
After starting at 900 mg daily, you wait 5 to 7 days before the first blood level check. This waiting period matters because lithium takes 4 to 5 days to reach steady state in the body. Checking levels earlier gives an inaccurate reading that could lead to overshooting the target.
If the level comes back below the target range, the dose is increased, typically in 200 mg increments. After each adjustment, you wait another 5 to 7 days, then recheck levels. This cycle of adjust, wait, and retest continues until two similar blood results fall within the therapeutic range at the same dose. For most people, the process takes 2 to 4 weeks, though it can stretch longer if side effects require smaller steps or slower pacing.
During acute manic episodes, the total daily dose often reaches 1,200 to 1,800 mg to achieve levels in the 0.8 to 1.2 mEq/L range. Once symptoms stabilize, the dose is usually reduced to a maintenance range of 600 to 1,200 mg daily, targeting 0.8 to 1.0 mEq/L.
Getting the Blood Draw Right
The accuracy of lithium levels depends entirely on when blood is drawn. The standard protocol is a trough level, meaning the sample is taken 12 hours after the last dose, right before the next one. For someone taking lithium three times daily, this usually means a morning blood draw before the first dose of the day. Levels drawn at other times will be artificially high and could lead to unnecessary dose reductions.
For people on once-daily extended-release lithium, there has been debate about whether a 24-hour post-dose draw is more appropriate. However, research shows that at 12 hours after a dose, blood levels for immediate-release and extended-release formulations are essentially identical. So 12 hours remains the standard timing for both.
Monitoring During Titration
Blood levels should be checked weekly during the active titration phase until two consistent results land within the target range at the same dose. After that, monitoring gradually spaces out. Most guidelines recommend checking levels every 1 to 3 months for the first year, then every 3 to 6 months once the dose is stable.
Beyond lithium levels alone, kidney function, thyroid function, and calcium should be assessed every 6 months for anyone on long-term therapy. Lithium can gradually impair kidney filtration and suppress thyroid hormone production. If kidney markers start trending in the wrong direction across two or more tests, lithium levels need closer monitoring and the overall treatment plan may need reassessment.
Recognizing Toxicity
Lithium toxicity is one of the main risks during titration, and it can develop even at doses close to the therapeutic range. The symptoms follow a predictable pattern tied to blood levels:
- Mild toxicity (1.5 to 2.5 mEq/L): nausea, vomiting, tremor, fatigue, and sluggishness. These overlap with normal early side effects, which is why blood levels rather than symptoms alone guide dosing decisions.
- Moderate toxicity (2.5 to 3.5 mEq/L): confusion, agitation, delirium, rapid heart rate, and muscle stiffness.
- Severe toxicity (above 3.5 mEq/L): seizures, coma, dangerously low blood pressure, and high body temperature. This is a medical emergency.
Several common situations can push lithium levels higher without any change in dose. Dehydration from illness, heavy sweating, or reduced fluid intake concentrates lithium in the blood. Certain medications, particularly some anti-inflammatory painkillers and blood pressure drugs, reduce the kidneys’ ability to clear lithium. Any new medication should be checked for interactions, and extra caution with hydration during hot weather or gastrointestinal illness is important throughout treatment.
Adjustments for Older Adults
Kidney function naturally declines with age, which directly affects how quickly the body clears lithium. Older adults typically need lower starting doses, often half the standard amount, and more conservative titration increments. Target blood levels for this group are frequently kept in the lower end of the therapeutic range, around 0.6 to 0.8 mEq/L, to reduce the risk of toxicity while still maintaining mood stability. More frequent blood monitoring during titration and throughout maintenance is standard.
What Stabilization Looks Like
Once a stable dose is reached, the daily routine becomes straightforward: take the prescribed dose at consistent times, get blood drawn on schedule, stay well hydrated, and watch for any new symptoms. Most side effects that appear during titration, like mild tremor, increased thirst, or slight nausea, either improve over weeks or can be managed with dose adjustments or timing changes.
Lithium levels aren’t static even after stabilization. Weight changes, new medications, shifts in kidney function, and changes in diet or hydration can all move levels up or down. That ongoing monitoring every few months is what keeps the dose in the right range over years of treatment.